212 related articles for article (PubMed ID: 3882569)
1. Cellular and extracellular protein antigens of Treponema pallidum synthesized during in vitro incubation of freshly extracted organisms.
Stamm LV; Bassford PJ
Infect Immun; 1985 Mar; 47(3):799-807. PubMed ID: 3882569
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum.
Baseman JB; Hayes EC
J Exp Med; 1980 Mar; 151(3):573-86. PubMed ID: 6987326
[TBL] [Abstract][Full Text] [Related]
3. Changes in the cell surface properties of Treponema pallidum that occur during in vitro incubation of freshly extracted organisms.
Stamm LV; Hodinka RL; Wyrick PB; Bassford PJ
Infect Immun; 1987 Sep; 55(9):2255-61. PubMed ID: 3305368
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the humoral immune response to Treponema pallidum in the different stages of untreated human syphilis.
Moskophidis M
Zentralbl Bakteriol; 1989 Jul; 271(2):171-9. PubMed ID: 2673265
[TBL] [Abstract][Full Text] [Related]
5. Analysis of serum IgG against Treponema pallidum protein antigens in experimentally infected rabbits.
Alderete JF; Baseman JB
Br J Vener Dis; 1981 Oct; 57(5):302-8. PubMed ID: 7028207
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of immunoglobulins M and G immune response to protein antigens of Treponema pallidum in human syphilis.
Moskophidis M; Müller F
Infect Immun; 1984 Jan; 43(1):127-32. PubMed ID: 6360891
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in experimental syphilis: identification of treponemal antigens and specific antibodies to treponemal antigens in isolated complexes.
Baughn RE; Adams CB; Musher DM
Infect Immun; 1983 Nov; 42(2):585-93. PubMed ID: 6358026
[TBL] [Abstract][Full Text] [Related]
8. Purification of a Reiter treponemal protein antigen that is immunologically related to an antigen in Treponema pallidum.
Petersen CS; Pedersen NS; Axelsen NH
Infect Immun; 1982 Mar; 35(3):974-8. PubMed ID: 6175580
[TBL] [Abstract][Full Text] [Related]
9. Antigenic cross-reactivity between Borrelia burgdorferi, Borrelia recurrentis, Treponema pallidum, and Treponema phagedenis.
Luther B; Moskophidis M
Zentralbl Bakteriol; 1990 Nov; 274(2):214-26. PubMed ID: 2085371
[TBL] [Abstract][Full Text] [Related]
10. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.
Norris SJ
Microbiol Rev; 1993 Sep; 57(3):750-79. PubMed ID: 8246847
[TBL] [Abstract][Full Text] [Related]
11. Complement activation limits the rate of in vitro treponemicidal activity and correlates with antibody-mediated aggregation of Treponema pallidum rare outer membrane protein.
Blanco DR; Walker EM; Haake DA; Champion CI; Miller JN; Lovett MA
J Immunol; 1990 Mar; 144(5):1914-21. PubMed ID: 2407784
[TBL] [Abstract][Full Text] [Related]
12. Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.
Lukehart SA; Baker-Zander SA; Gubish ER
J Immunol; 1982 Aug; 129(2):833-8. PubMed ID: 6177786
[TBL] [Abstract][Full Text] [Related]
13. Identification and preliminary characterization of Treponema pallidum protein antigens expressed in Escherichia coli.
Stamm LV; Kerner TC; Bankaitis VA; Bassford PJ
Infect Immun; 1983 Aug; 41(2):709-21. PubMed ID: 6347894
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of immunological cross-reactivity between Treponema pallidum and Treponema pertenue.
Baker-Zander SA; Lukehart SA
Infect Immun; 1983 Nov; 42(2):634-8. PubMed ID: 6358028
[TBL] [Abstract][Full Text] [Related]
15. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum (Nichols).
Jones SA; Marchitto KS; Miller JN; Norgard MV
J Exp Med; 1984 Nov; 160(5):1404-20. PubMed ID: 6208310
[TBL] [Abstract][Full Text] [Related]
17. Identification of glycosylated protein antigens of Treponema pallidum and Treponema phagedenis.
Moskophidis M; Müller F
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):468-76. PubMed ID: 3901616
[TBL] [Abstract][Full Text] [Related]
18. Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans.
Baker-Zander SA; Hook EW; Bonin P; Handsfield HH; Lukehart SA
J Infect Dis; 1985 Feb; 151(2):264-72. PubMed ID: 3881539
[TBL] [Abstract][Full Text] [Related]
19. Molecular specificities of monoclonal antibodies directed against virulent Treponema pallidum.
Marchitto KS; Selland-Grossling CK; Norgard MV
Infect Immun; 1986 Jan; 51(1):168-76. PubMed ID: 3510168
[TBL] [Abstract][Full Text] [Related]
20. Cloning structural genes for Treponema pallidum immunogens and characterisation of recombinant treponemal surface protein, P2 (P2 star).
Peterson KM; Baseman JB; Alderete JF
Genitourin Med; 1987 Oct; 63(5):289-96. PubMed ID: 3315959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
